Journal article
Screening out irrelevant cell-based models of disease
- Abstract:
-
The common and persistent failures to translate promising preclinical drug candidates into clinical success highlight the limited effectiveness of disease models currently used in drug discovery. An apparent reluctance to explore and adopt alternative cell- and tissue-based model systems, coupled with a detachment from clinical practice during assay validation, contributes to ineffective translational research. To help address these issues and stimulate debate, here we propose a set of princi...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, jpeg, 564.0KB)
-
(Accepted manuscript, jpeg, 886.5KB)
-
(Accepted manuscript, jpeg, 535.3KB)
-
(Accepted manuscript, jpeg, 475.7KB)
-
(Accepted manuscript, pdf, 424.5KB)
-
- Publisher copy:
- 10.1038/nrd.2016.175
Authors
Funding
Bibliographic Details
- Publisher:
- Nature Publishing Group Publisher's website
- Journal:
- Nature Reviews Drug Discovery Journal website
- Volume:
- 15
- Issue:
- 11
- Pages:
- 751–769
- Publication date:
- 2016-09-12
- Acceptance date:
- 2016-01-01
- DOI:
- EISSN:
-
1474-1784
- ISSN:
-
1474-1776
- Pmid:
-
27616293
- Source identifiers:
-
642715
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:642715
- UUID:
-
uuid:235b737c-1b92-4b81-9819-ab300ce36eb9
- Local pid:
- pubs:642715
- Deposit date:
- 2016-09-27
Terms of use
- Copyright holder:
- Horvath et al
- Copyright date:
- 2016
- Notes:
- © the Author(s), published by Nature Publishing Group. This is the accepted manuscript version of the article. The final version is available online from Nature Publishing Groupat: https://doi.org/10.1038/nrd.2016.175
If you are the owner of this record, you can report an update to it here: Report update to this record